Endo-PAT2000 adds an important dimension to cardiovascular medicine by enabling physicians to reliably, easily and non-invasively measure endothelial function.

Endo-PAT2000 utilizes Itamar Medical's PAT technology to non-invasively measure changes in the PAT signal in response to a five-minute occlusion of the brachial artery. This arterial provocation elicits an endothelial-dependent vasodilatation which causes an increase of the PAT signal.

The PAT signal, recorded from the distal phalanx of a finger by the pneumatic finger probes, is analyzed automatically using proprietary advanced Digital Signal Processing algorithms. The data is presented in a comprehensive report which is available within seconds of completing the test.

Endo-PAT2000

• Noninvasive
• Easy to use - user independent
• Automatic analysis
• Supports both clinical and research applications
• Reliable and reproducible results
• FDA cleared and CE marked

The medical community has long sought a cost-effective, reliable, non-invasive method to improve the detection of endothelial dysfunction, in order to screen larger segments of the population safely and reliably, and to enhance follow-up for sufferers of cardiac disease. Itamar Medical's Endo-PAT2000 is meeting this challenge, and is ideally suited to enhance the traditional clinical settings’ diagnostic capabilities. The Endo-PAT2000 can be used in any setting, from hospital bedside to outpatient clinic.

The Endo–PAT2000 – impressive numbers:

• Install base of over 300 devices
• In over 40 countries
• Over 70 publications in peer-reviewed journals and abstracts in scientific conferences
• Over 100,000 tests performed
• Incorporated in over 10 Pharma clinical-phase trials
• Over 10 studies with over 1,000 subjects
• Incorporated in over 100 study protocols